CIK 0001787400
- Non-accelerated filer
- Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474515206
- Phone
- +1 925-407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Shook David acquired 23,421 shares (grant or award)
- 4 Planned sale Chief Legal Officer sold 3,396 shares at $8.00 ($27,168)
- 4 Open-market sale Chief Scientific Officer sold 456 shares at $5.60 ($2,554)
- 4 Open-market sale Chief Executive Officer sold 1,770 shares at $5.60 ($9,912)
- 4 Open-market sale Chief Medical Officer sold 456 shares at $5.60 ($2,554)
- 4 Open-market sale Chief Legal Officer sold 727 shares at $5.60 ($4,071)
- 4 Open-market sale Chief Technical Officer sold 229 shares at $5.60 ($1,282)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 3,000,000 shares at $10.00 ($30,000,000)
- 4 Open-market buy Director bought 2,000,000 shares at $10.00 ($20,000,000)
- 4 Returned to the company Chief Executive Officer returned 150,000 shares (to the company)
Page 3 of 11 · 218 filings